Takaaki Chou

Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial

Saad Z. Usmani, Fredrik Schjesvold, Albert Oriol et al. · The Lancet Haematology · 2019 · 237 citations · Full text

Hematological Malignancy, Medicine, Immunology +7

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 231 citations · Full text

Regenerative Medicine, Cell Therapy, Transplantation +7

Clinical profiles of multiple myeloma in Asia—An Asian Myeloma Network study

Jae Hoon Lee, Jin Seok Kim, Chang Ki Min et al. · American Journal of Hematology · 2014 · 122 citations · Full text

Survival of Multiple Myeloma Patients Aged 65-70 Years in the Era of Novel Agents and Autologous Stem Cell Transplantation

Shuji Ozaki, Takeshi Harada, Takayuki Saitoh et al. · Acta Haematologica · 2014 · 51 citations · Full text

Comparable outcomes between autologous and allogeneic transplant for adult acute myeloid leukemia in first CR

Motonori Mizutani, Masahiko Hara, Hiroyuki Fujita et al. · Bone Marrow Transplantation · 2016 · 49 citations

Hematological Malignancy, Allogeneic Transplant, Transplantation +10